News
13h
Zacks.com on MSNPFE's Hympavzi Phase III Hemophilia Study With Inhibitors Meets GoalPfizer's Hympavzi meets key phase III goals, demonstrating a significant reduction in bleeding in hemophilia patients with ...
UK-based celebrity nutritionist Rose Ferguson previously revealed an uptick in the her clients who are worried about facial ...
3h
News-Medical.Net on MSNAdvancing transdermal insulin delivery through innovative formulation strategiesAnnouncing a new publication for Acta Materia Medica journal. The prevalence of diabetes is increasing and expected to become ...
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
A team of researchers at Rowan University has developed a groundbreaking injectable biomaterial that could significantly improve recovery outcomes following spinal cord injuries. The study, recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results